About me
Feisal Othman is a drug safety and risk management professional with over 16 years of experience in various roles in healthcare and medication safety, currently serving as a Benefit-Risk Assessment Lead at Bristol Myers Squibb. His background includes developing and overseeing global risk management strategies, regulatory compliance, development of structured benefit-risk assessment processes and leading cross-functional project teams. Feisal's strategic insights have significantly contributed to successful product launches and regulatory approvals worldwide. He earned his Doctor of Pharmacy Degree from Midwestern University and Bachelor of Science from the University of Illinois at Chicago.
